These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 23725514)
21. Discovery of USP7 small-molecule allosteric inhibitors. Engström O; Belda O; Kullman-Magnusson M; Rapp M; Böhm K; Paul R; Henderson I; Derbyshire D; Karlström S; Parkes KEB; Zhao H Bioorg Med Chem Lett; 2020 Oct; 30(20):127471. PubMed ID: 32781219 [TBL] [Abstract][Full Text] [Related]
22. Identification of Hedgehog signaling inhibitors with relevant human exposure by small molecule screening. Lipinski RJ; Bushman W Toxicol In Vitro; 2010 Aug; 24(5):1404-9. PubMed ID: 20434536 [TBL] [Abstract][Full Text] [Related]
23. Design of Hedgehog pathway inhibitors for cancer treatment. Bariwal J; Kumar V; Dong Y; Mahato RI Med Res Rev; 2019 May; 39(3):1137-1204. PubMed ID: 30484872 [TBL] [Abstract][Full Text] [Related]
25. Hedgehog Signaling: From Basic Biology to Cancer Therapy. Wu F; Zhang Y; Sun B; McMahon AP; Wang Y Cell Chem Biol; 2017 Mar; 24(3):252-280. PubMed ID: 28286127 [TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of benzo[d]oxazol-2(3H)-one derivatives as the first potent and selective small-molecule inhibitors of chromodomain protein CDYL. Yang L; Liu Y; Fan M; Zhu G; Jin H; Liang J; Liu Z; Huang Z; Zhang L Eur J Med Chem; 2019 Nov; 182():111656. PubMed ID: 31494467 [TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of inhibitors of Hedgehog signaling based on the alkaloid cyclopamine. Winkler JD; Isaacs A; Holderbaum L; Tatard V; Dahmane N Org Lett; 2009 Jul; 11(13):2824-7. PubMed ID: 19552464 [TBL] [Abstract][Full Text] [Related]
28. Studies directed toward the elucidation of the pharmacophore of steroid-based Sonic Hedgehog signaling inhibitors. Isaacs AK; Xiang C; Baubet V; Dahmane N; Winkler JD Org Lett; 2011 Oct; 13(19):5140-3. PubMed ID: 21905689 [TBL] [Abstract][Full Text] [Related]
29. Discovery libraries targeting the major enzyme classes: the serine hydrolases. Otrubova K; Srinivasan V; Boger DL Bioorg Med Chem Lett; 2014 Aug; 24(16):3807-13. PubMed ID: 25037918 [TBL] [Abstract][Full Text] [Related]
30. Speeding drug discovery targeting RNAs: An iterative "RNA selection-compounds screening cycle" for exploring RNA-small molecule pairs. Furuzono T; Murata A; Okuda S; Mizutani K; Adachi T; Nakatani K Bioorg Med Chem; 2021 Apr; 36():116070. PubMed ID: 33773376 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors. Nagao S; Yamane Y; Funasaka S; Tanaka K; Miyazaki K; Kotake Y; Kamata J; Watanabe-Miyano S; Toyama O; Ozawa Y; Mizui Y; Okamoto K; Ito D Bioorg Med Chem; 2014 Oct; 22(19):5513-29. PubMed ID: 25139751 [TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of small molecule inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening. Zhang M; Zhu W; Ding N; Zhang W; Li Y Bioorg Med Chem Lett; 2013 Apr; 23(7):2225-9. PubMed ID: 23434226 [TBL] [Abstract][Full Text] [Related]
33. Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma. Tsai CL; Hsu FM; Tzen KY; Liu WL; Cheng AL; Cheng JC J Gastroenterol Hepatol; 2015 Aug; 30(8):1317-24. PubMed ID: 25682950 [TBL] [Abstract][Full Text] [Related]
34. Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists. Frank-Kamenetsky M; Zhang XM; Bottega S; Guicherit O; Wichterle H; Dudek H; Bumcrot D; Wang FY; Jones S; Shulok J; Rubin LL; Porter JA J Biol; 2002 Nov; 1(2):10. PubMed ID: 12437772 [TBL] [Abstract][Full Text] [Related]
35. Discovery of the first selective, small-molecule GFRα2/3 inhibitors through DNA-encoded library technology. Johnson SL; Missig G; Wang M; Ouk K; Gupta K; Nguyen HN; Toh MF; Ho TS; Gray D; Zhang H; Choi-Sledeski YM; Barberis C; Stone DJ; Pin S; Lim J Bioorg Med Chem Lett; 2024 Sep; 110():129889. PubMed ID: 39004318 [TBL] [Abstract][Full Text] [Related]
36. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926). Tremblay MR; Lescarbeau A; Grogan MJ; Tan E; Lin G; Austad BC; Yu LC; Behnke ML; Nair SJ; Hagel M; White K; Conley J; Manna JD; Alvarez-Diez TM; Hoyt J; Woodward CN; Sydor JR; Pink M; MacDougall J; Campbell MJ; Cushing J; Ferguson J; Curtis MS; McGovern K; Read MA; Palombella VJ; Adams J; Castro AC J Med Chem; 2009 Jul; 52(14):4400-18. PubMed ID: 19522463 [TBL] [Abstract][Full Text] [Related]
37. The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitors. Xin M; Wen J; Tang F; Tu C; Shen H; Zhao X Bioorg Med Chem Lett; 2013 Dec; 23(24):6777-83. PubMed ID: 24176396 [TBL] [Abstract][Full Text] [Related]
38. Identification of small molecule sphingomyelin synthase inhibitors. Deng X; Lin F; Zhang Y; Li Y; Zhou L; Lou B; Li Y; Dong J; Ding T; Jiang X; Wang R; Ye D Eur J Med Chem; 2014 Feb; 73():1-7. PubMed ID: 24374347 [TBL] [Abstract][Full Text] [Related]
39. Discovery of Small Molecules that Induce the Degradation of Huntingtin. Tomoshige S; Nomura S; Ohgane K; Hashimoto Y; Ishikawa M Angew Chem Int Ed Engl; 2017 Sep; 56(38):11530-11533. PubMed ID: 28703441 [TBL] [Abstract][Full Text] [Related]